IRCT20220512054829N9 IRCT 2026-08-04 Kashan University of Medical Sciences Comparing the effects of jujube syrup with desloratadine on chronic urticaria The comparison of jujube compound herbal medicine containing jujube, coriander, fumaria, lentil and chicory with desloratadine on chronic urticaria 2026-06-05 anticipated 60 Recruiting https://irct.ir/trial/89536 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is performed using the permuted block randomization method, so that first all 4 blocks containing two codes A and B are prepared (6 blocks), then random blocks are selected by placement using a random number table. These blocks form a sequence of codes A and B equal to the sample size, and each code is randomly assigned to one of the groups. All randomization steps will be performed on the site https://ctrandomization.cancer.gov and using the Clinical Trial Randomization Tool option. The list of relevant codes will remain in the formulation department of Barij Essence Pharmaceutical Company until the completion of the project. This method will provide both blinding and randomization, Blinding description: The herbal syrup under study is manufactured in the formulation department of Barij Essans Pharmaceutical Company and is identical to Desloratadine (Neotadine) syrup (manufactured by Adora Teb Iran Company) in terms of appearance, size, and color of the glass and is provided in identical packaging. Then, it is coded based on codes previously prepared using a random number table and block randomization method. And it is provided to the project implementers in a mixed form in a carton. 3 Chronic urticaria. Intervention 1: Intervention group: Recipients of jujube syrup manufactured by Barij Essence Pharmaceutical Company, containing jujube, chicory, horsetail, lentils and coriander extracts, 10 cc twice a day for one month. Intervention 2: Control group: Recipients of desloratadine syrup manufactured by Iran Darou Pharmaceutical Company, 10 cc twice a day for one month. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Given that the sponsor of this study is a pharmaceutical company, it is necessary to obtain approval from the company and the university before publishing the study data.